Replies to post #36592 on Biotech Values

[DewDiligence]

>Based on the above, considering the similar responses [of Baraclude and Tyzeka] to Lamivudine, you'd need to run a very large head to head trial to see any distinction at one year.<

A non-inferiority trial would work :-)